| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
BASIC SCIENCE |



*Department of Nephrology and Hypertension, Cincinnati Childrens Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio; and
Department of Nephrology, College of Physicians and Surgeons, Columbia University, New York, New York
Correspondence to Dr. Prasad Devarajan, Nephrology and Hypertension, MLC 7022, Cincinnati Childrens Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229-3039. Phone: 513-636-4531; Fax: 513-636-7407; E-mail: prasad.devarajan{at}cchmc.org
Acute renal failure secondary to ischemic injury remains a common problem, with limited and unsatisfactory therapeutic options. Neutrophil gelatinase-associated lipocalin (NGAL) was recently shown to be one of the maximally induced genes early in the postischemic kidney. In this study, the role of NGAL in ischemic renal injury was explored. Intravenous administration of purified recombinant NGAL in mice resulted in a rapid uptake of the protein predominantly by proximal tubule cells. In an established murine model of renal ischemia-reperfusion injury, intravenous NGAL administered before, during, or after ischemia resulted in marked amelioration of the morphologic and functional consequences, as evidenced by a significant decrease in the histopathologic damage to tubules and in serum creatinine measurements. NGAL-treated animals also displayed a reduction in the number of apoptotic tubule cells and an increase in proliferating proximal tubule cells after ischemic injury. The results indicate that NGAL may represent a novel therapeutic intervention in ischemic acute renal failure, based at least in part on its ability to tilt the balance of tubule cell fate toward survival.
This article has been cited by other articles:
![]() |
S. Lee, J.-Y. Park, W.-H. Lee, H. Kim, H.-C. Park, K. Mori, and K. Suk Lipocalin-2 Is an Autocrine Mediator of Reactive Astrocytosis J. Neurosci., January 7, 2009; 29(1): 234 - 249. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Devarajan Neutrophil gelatinase-associated lipocalin--an emerging troponin for kidney injury Nephrol. Dial. Transplant., December 1, 2008; 23(12): 3737 - 3743. [Full Text] [PDF] |
||||
![]() |
E. Vinuesa, A. Sola, M. Jung, V. Alfaro, and G. Hotter Lipocalin-2-induced renal regeneration depends on cytokines Am J Physiol Renal Physiol, November 1, 2008; 295(5): F1554 - F1562. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Tong, A. B. Kunnumakkara, H. Wang, Y. Matsuo, P. Diagaradjane, K. B. Harikumar, V. Ramachandran, B. Sung, A. Chakraborty, R. S. Bresalier, et al. Neutrophil Gelatinase-Associated Lipocalin: A Novel Suppressor of Invasion and Angiogenesis in Pancreatic Cancer Cancer Res., August 1, 2008; 68(15): 6100 - 6108. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bennett, C. L. Dent, Q. Ma, S. Dastrala, F. Grenier, R. Workman, H. Syed, S. Ali, J. Barasch, and P. Devarajan Urine NGAL Predicts Severity of Acute Kidney Injury After Cardiac Surgery: A Prospective Study Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 665 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Giles and C Putterman Autoantibodies and other biomarkers - pathological consequences (1) Lupus, March 1, 2008; 17(3): 241 - 246. [PDF] |
||||
![]() |
R. Marsell, T. Krajisnik, H. Goransson, C. Ohlsson, O. Ljunggren, T. E. Larsson, and K. B. Jonsson Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23 Nephrol. Dial. Transplant., March 1, 2008; 23(3): 827 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ronco, J. A. Kellum, R. Bellomo, and A. A. House Potential Interventions in Sepsis-Related Acute Kidney Injury Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 531 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lee, J. Lee, S. Kim, J.-Y. Park, W.-H. Lee, K. Mori, S.-H. Kim, I. K. Kim, and K. Suk A Dual Role of Lipocalin 2 in the Apoptosis and Deramification of Activated Microglia J. Immunol., September 1, 2007; 179(5): 3231 - 3241. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Jo, M. H. Rosner, and M. D. Okusa Pharmacologic Treatment of Acute Kidney Injury: Why Drugs Haven't Worked and What Is on the Horizon Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 356 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Schmidt-Ott, K. Mori, J. Y. Li, A. Kalandadze, D. J. Cohen, P. Devarajan, and J. Barasch Dual Action of Neutrophil Gelatinase-Associated Lipocalin J. Am. Soc. Nephrol., February 1, 2007; 18(2): 407 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Devarajan Update on Mechanisms of Ischemic Acute Kidney Injury J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1503 - 1520. [Full Text] [PDF] |
||||
![]() |
T. Berger, A. Togawa, G. S. Duncan, A. J. Elia, A. You-Ten, A. Wakeham, H. E. H. Fong, C. C. Cheung, and T. W. Mak Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury PNAS, February 7, 2006; 103(6): 1834 - 1839. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Gwira, F. Wei, S. Ishibe, J. M. Ueland, J. Barasch, and L. G. Cantley Expression of Neutrophil Gelatinase-associated Lipocalin Regulates Epithelial Morphogenesis in Vitro J. Biol. Chem., March 4, 2005; 280(9): 7875 - 7882. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673